Background TSLP has been described as a "master T H 2 cytokine" with pleiotropic effects. Recent research shows that TSLP can directly activate mast cells and CB CD34
+ hemopoietic progenitor cells (HPC), with release of T H 2 cytokines/chemokines in a TSLP-dependent manner [1, 2] . Additionally, TSLP may modulate the function of CD34 + cells via changes in hemopoietic cytokine receptors (HCR), which are altered in CB CD34 + cells of atopic at-risk infants [3] . In this study, we aimed to characterize HCR expression on CD34 + cells and to examine CD34 + cell differentiation following TSLP stimulation.
Methods

Purified CD34
+ HPC isolated from CB were stimulated with rTSLP (0.1, 0.5, and 1 ng/ml), with or without IL-33 then stained for surface expression of HCR, or used for methylcellulose colony assays. Flow cytometric staining of CD34 + cells were performed using monoclonal antibodies to CD34, CD45, polyclonal rabbit antibodies to IL-3Rα, IL-5Rα, and GM-CSFRα, and compared to isotype controls. CD34 + cells were cultured in semisolid methylcellulose culture in the presence of optimal doses of recombinant cytokines, IL-3, IL-5, and GM-CSF. Following 14 days of culture, mean numbers of Eo/B CFU were enumerated.
Results
Overnight stimulation with TSLP (1 ng/mL) significantly enhanced mean expression of IL-5Rα on CB CD34 + cells (n=8, p=0.04) and significantly increased Eo/B CFU production to IL-5 and GM-CSF (n=6, p<0.05). Additionally, TSLP sufficiently induced the differentiation of CD34 + progenitors into eosinophils.
Conclusion
Our findings suggest key roles for TSLP in influencing CB HPC eosinophilic lineage commitment eventuating in allergic inflammation and disease in early life.
